A prenylation inhibitor prevents production of infectious hepatitis delta virus particles - Wikidata - wikimedia - TriplyDB

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

http://www.wikidata.org/entity/Q39684955

about

By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression Attacking pathogens through their hosts Management of hepatitis delta: Need for novel therapeutic options Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production Interferon impedes an early step of hepatitis delta virus infection.Meta-analysis: antiviral treatment for hepatitis D.The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology Interferon-stimulated genes: a complex web of host defenses.Protein prenylation: enzymes, therapeutics, and biotechnology applications.Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.Hepatitis D Virus: A Call to Screening.Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.Microfluidic large scale integration of viral-host interaction analysis.Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.Therapy of Delta Hepatitis.Hepatitis D Virus Replication.The future of liver transplantation for viral hepatitis.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus.Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.Investigational drugs in development for Hepatitis D.Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells.Recent advances in managing hepatitis D Chronic hepatitis D at a standstill: where do we go from here?Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.Global strategies are required to cure and eliminate HBV infection.Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

P2860

Q24564116-1CB8B4E6-BA67-4690-A8E7-244146B9B449 Q27473132-FFFBB371-3931-40BE-8810-529F5C9F98C9 Q28082312-CE1A5A99-A9A0-4376-BC9C-76088676E8C6 Q33930361-70FE31F6-09AB-4D8A-AA48-5A18097440F5 Q33979916-BAB7FCC7-2945-47B4-B7EA-9F0FAEB61D8E Q34138307-DE276B23-15AB-49DF-A45B-FD5ACE39CB31 Q34338519-0065ADA1-ABB0-493C-9999-D969FFA1C7F3 Q34405609-0454B914-B0A4-438D-9C2B-F45C427CD65F Q34992469-00277B8E-BF9C-4861-ABF3-DA38BF19FD97 Q36428213-B4FD767D-6DF4-407F-82A9-7185BA434D46 Q37182821-1CA55584-2429-49FE-9D46-E7F81DBCFF81 Q37743065-3C6BF51D-7C81-40AA-A2AC-8C710EA2C38B Q38104272-946CF3A5-542D-4062-858A-B1C2E0C09BCD Q38296605-999F47B5-6B39-420E-80D8-BD3FA4A1F679 Q38357110-8DEE7F6A-49D0-4D44-9228-F7F2231DD4EC Q38562544-431AD2C6-8BB8-4737-9123-F7E64BDA1668 Q38622670-A71539E9-4436-4850-BCD6-45DBFD71B78D Q38774864-DF3C2484-FD16-4355-A7ED-185837A1A79E Q39414876-CD179C20-DE88-4D78-B025-36558F2CB203 Q39793276-5C3A89AC-9348-48E1-BDCD-47A1B6BB4083 Q39847241-E9F3690D-3D52-4EEB-A3E0-4E2F84763FDC Q39881707-EBC77C3A-37CF-451D-B07F-32BE63783493 Q40113645-D6E06246-9B08-48AA-9F05-AA58057BF2B6 Q41535966-4891C5EA-6DF9-49E4-A30A-48DAF9B75F85 Q41588940-6DF23243-6CB7-4AD9-A1AF-43BBF02E71DA Q43492653-4164B9B5-CC1F-478F-84A0-D1CC801E4FA3 Q43629800-6EC42257-3314-434D-B77C-EF0EB8BA55AD Q47239374-F95AB31D-CB0C-4DC8-B6B1-5128E3C779B3 Q48860247-34A787CF-37B1-486C-86E0-17A9BA4A9DD1 Q52714949-00827C0C-086E-414E-AC66-C7AD1205F860

P2860

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

http://www.wikidata.org/entity/Q39684955

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

@en

A prenylation inhibitor preven ...... patitis delta virus particles.

@nl

type

label

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

@en

A prenylation inhibitor preven ...... patitis delta virus particles.

@nl

prefLabel

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

@en

A prenylation inhibitor preven ...... patitis delta virus particles.

@nl

P1433

Q39684955-517E854D-C0F2-4747-AE6E-3484369E2F40

P1476

Q39684955-0A53D488-2FED-484F-A785-E71116317EE0

P2093

Q39684955-3DCCADE4-355B-4EE3-A9E6-4D2614BA1A04

Q39684955-4CB9E2D4-B768-4AEE-BDB4-4161002E34D8

Q39684955-6AC0F22A-9BAE-491B-B7FD-CBFBD1E5C7E0

Q39684955-773FF42D-DE16-46E0-8DAB-7D78FDD68329

Q39684955-9C19F6E0-49A0-4ED3-BB4F-755DF6049431

Q39684955-C5464153-68B4-4407-852A-C294AACC2B7B

Q39684955-D02C6ECF-7F32-4225-B330-C582CA16DD8C

P2860

Q39684955-012A57BE-DFBA-47AB-9BF6-30DC7BE99180

Q39684955-07394C51-B56D-4DCD-AEF5-6807DB5DC400

Q39684955-0DD70EF2-08F7-4ACA-858E-6FB17A661256

Q39684955-0E84B639-4DC7-4908-A1E1-79E314DCCCD8

Q39684955-106A7F01-0A36-4F49-B202-5DC0DEB813C7

Q39684955-128AE22F-B514-4137-84FD-BF06B1EB0EF5

Q39684955-15142B82-9E51-4E44-B0A1-6512266ADBCB

Q39684955-1971796D-7E10-4D57-A4C6-24963E7E07B9

Q39684955-1DD6B535-2E80-4992-A835-AA0F9BC60BD5

Q39684955-235097E8-5AE4-4B73-8A97-FDAE944D8FDA

P304

Q39684955-34080FCB-A468-4312-BC6F-633C0AC8B4FE

P31

Q39684955-6BF1B6F3-D26B-457F-8064-01A76F063BD5

P356

Q39684955-F8C439F9-5333-41E6-9BC6-A3AA8FD435D8

P407

Q39684955-C625228A-7DE3-4D9F-8D69-5466AE53BF7B

P433

Q39684955-4ECF96D8-6027-4967-A7C2-7FC2F82E9E8C

P478

Q39684955-4E0DC607-9BE0-414F-9CC2-3072A2FF1700

P577

Q39684955-A752F481-F581-49CA-B37D-5497B1FDB5B5

P698

Q39684955-DD6135C7-EC01-4027-961C-BB7BF5220C97

P932

Q39684955-F5E07E34-5209-4FA6-916C-51BCA88C5E5D

P356

JVI.76.20.10465-10472.2002

P1433

Journal of Virology

P1476

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

@en

P2093

Bruno B Bordier

http://www.w3.org/2001/XMLSchema#string

Harry B Greenberg

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Glenn

http://www.w3.org/2001/XMLSchema#string

John L Casey

http://www.w3.org/2001/XMLSchema#string

Kazuo Ohashi

http://www.w3.org/2001/XMLSchema#string

Mark A Kay

http://www.w3.org/2001/XMLSchema#string

Patricia L Marion

http://www.w3.org/2001/XMLSchema#string

P2860

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes

All ras proteins are polyisoprenylated but only some are palmitoylated

A specific base transition occurs on replicating hepatitis delta virus RNA

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines

Posttranslational modification of proteins by isoprenoids in mammalian cells

Protein prenylation: molecular mechanisms and functional consequences

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development.

Hepatitis delta virus: molecular biology, pathogenesis and immunology.

Structure, sequence and expression of the hepatitis delta (delta) viral genome.

P304

10465-10472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.20.10465-10472.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12239323

http://www.w3.org/2001/XMLSchema#string

P932

136538

http://www.w3.org/2001/XMLSchema#string